Breast tissue expanders and implantable cardioverter-defibrillator: An unusual interaction

Breast tissue expanders and implantable cardioverter-defibrillator: An unusual interaction

Bibliographic Details
Main Authors:	Malik Muhammad Khurram Sher Khan, MD, Malik Muhammad Humayun Sher Khan, MD, Aaron Tolan, MD, Darryl Elmouchi, MD, FHRS, Carlos E. Tavera, MD, FACP
Format:	Article
Language:	English
Published:	Elsevier 2015-07-01
Series:	HeartRhythm Case Reports
Subjects:	Breast tissue expander Implantable cardioverter-defibrillator Magnetic injection port Interaction Magnet mode conversion
Online Access:	http://www.sciencedirect.com/science/article/pii/S2214027115000111

Similar Items

Magnets and implantable cardioverter defibrillators: What′s the problem?
by: Yiliam F Rodriguez-Blanco, et al.
Published: (2013-01-01)

A novel cause of inappropriate subcutaneous implantable cardioverter-defibrillator therapies after a generator change
by: Timothy M. Markman, MD, et al.
Published: (2021-08-01)

Implantable cardioverter-defibrillator programming after first occurrence of ventricular tachycardia in the Multicenter Automatic Defibrillator Implantation Trial–Reduce Inappropriate Therapy (MADIT-RIT)Key Findings
by: Mehmet K. Aktas, MD, MBA, FHRS, et al.
Published: (2020-06-01)

Intermuscular pocket for subcutaneous implantable cardioverter defibrillator: Single-center experience
by: Paola Ferrari, MD, et al.
Published: (2016-06-01)

Subcutaneous implantable cardioverter-defibrillator placement in a patient with a preexisting transvenous implantable cardioverter-defibrillator
by: Mohammad-Ali Jazayeri, MD, et al.
Published: (2017-06-01)

The runaway defibrillator…A case of an implantable cardioverter-defibrillator that failed communication and deactivation with a magnet
by: Mahmoud Assaad, MD, et al.
Published: (2016-01-01)

Ventricular tachycardia detection with the subcutaneous implantable cardioverter-defibrillator: Tracing the cause of an absent tracing
by: Fadi Mansour, MD, et al.
Published: (2020-02-01)

Short-term Venous Patency after Implantation of Permanent Pacemakers or Implantable Cardioverter Defibrillators
by: Takeshi Nakae, MD, et al.
Published: (2010-01-01)

The Subcutaneous Implantable Cardioverter-Defibrillator: A Practical Review and Real-World Use and Application
by: Mark E. Panna Jr, MD, FACC, FHRS, et al.
Published: (2016-02-01)

Relationship between right and left ventricular function in candidates for implantable cardioverter defibrillator with low left ventricular ejection fraction
by: Laura Jimenez-Juan, MD, et al.
Published: (2017-04-01)

A broken lead to an open heart: implantable cardioverter defibrillator vegetations with lead fracture
by: George Horani, MD, et al.
Published: (2021-11-01)

Shoulder Joint Dislocation as an Unusual Complication of Defibrillation Threshold Testing Following Subcutaneous Implantable Cardioverter-Defibrillator Implantation
by: Amit Noheria, MBBS, SM, et al.
Published: (2014-11-01)

Efficacy of Additional Amiodarone Therapy in Patients with an Implantable Cardioverter-Defibrillator
by: Naomichi Matsumoto, MD, et al.
Published: (2010-01-01)

Quality of Life and Psychological Factors in Patients with Implantable Cardioverter Defibrillator
by: Akiko Suyama-Chishaki, MD PhD, et al.
Published: (2007-01-01)

Mortality and predictors of appropriate implantable cardioverter defibrillator therapy in Japanese patients with Multicenter Automatic Defibrillator Implantation Trial II criteria
by: Yoshimori An, MD, et al.
Published: (2017-02-01)

Epicardially placed implantable cardioverter-defibrillator for a child with congenital long QT syndrome
by: Hirotaro Sugiyama, MD, et al.
Published: (2017-06-01)

The Subcutaneous Implantable Cardioverter-Defibrillator: Not For All
by: Krishnakumar Nair, et al.
Published: (2014-07-01)

Ineffective implantable cardioverter-defibrillator shocks among patients on continuous left ventricular assist device support: Clinical characteristics and management
by: Malik Shehadeh, MD, et al.
Published: (2020-12-01)

Systemic infection due to subcutaneous implantable cardioverter-defibrillator implantation: Importance of early recognition and treatment of device pocket-related complications
by: Patrick M. Looser, MD, et al.
Published: (2017-01-01)

The wearable cardioverter-defibrillator is needed for most high-risk patients
by: Byron K. Lee, MD, MAS
Published: (2020-08-01)

An appropriate shock of the wearable cardioverter-defibrillator in an outpatient setting
by: Jun Kishihara, MD, et al.
Published: (2016-02-01)

The wearable cardioverter-defibrillator is not needed for most high-risk patients
by: Advay G. Bhatt, MD, FHRS, et al.
Published: (2020-08-01)

The association between defibrillation shock energy and acute cardiac damage in patients with implantable cardioverter defibrillators
by: Daisuke Ishigaki, M.D., et al.
Published: (2016-12-01)

2015 HRS/EHRA/APHRS/SOLAECE expert consensus statement on optimal implantable cardioverter-defibrillator programming and testing
by: Bruce L. Wilkoff, MD, FHRS, CCDS, et al.
Published: (2016-02-01)

Under-Utilization of Implantable Cardioverter Defibrillators in Patients with Heart Failure - The Current State of Sudden Cardiac Death Prophylaxis
by: Jayasree Pillarisetti, MD, et al.
Published: (2015-01-01)

“Atrial torsades de pointes” Induced by Low-Energy Shock From Implantable-Cardioverter Defibrillator
by: Ilknur Can, MD, et al.
Published: (2013-09-01)

Reuse Potential of Pacemakers and Implantable Cardioverter-defibrillators - Some Real World Data
by: S.P. Abhilash, et al.
Published: (2013-05-01)

An unusual cause of implantable cardioverter defibrillator malfunction: Twiddler syndrome
by: Ufuk Eryılmaz, et al.
Published: (2013-10-01)

Usefulness of the wearable cardioverter defibrillator in patients in the early post-myocardial infarction phase with high risk of sudden cardiac death: A single-center European experience
by: Yusuke Kondo, M.D., Ph.D., et al.
Published: (2015-10-01)

Managing cross talk between a subcutaneous implantable cardioverter-defibrillator and a dual-chamber unipolar pacemaker system
by: Konstantinos Kossidas, MD, FHRS, et al.
Published: (2017-12-01)

Initial experience with the subcutaneous implantable cardioverter-defibrillator in a single Japanese center
by: Nobuhiro Nishii, MD, et al.
Published: (2017-08-01)

Inappropriate shocks in a patient with a subcutaneous implantable cardioverter-defibrillator
by: Sana M. Al-Khatib, MD, MHS, FHRS, et al.
Published: (2016-11-01)

Monitoring zone-associated implantable cardioverter defibrillator shock: A case report
by: Hisayasu Matsuzaki, et al.
Published: (2012-08-01)

Two cases of inappropriate implantable cardioverter-defibrillator therapies due to T wave oversensing induced by body twisting
by: Nobuhiro Nishii, MD, et al.
Published: (2017-04-01)

A Tragic Case of Wearable Cardioverter-Defibrillator Failure
by: Ariel Vinas, MD, et al.
Published: (2021-02-01)

Influence of myopotential interference on the Wavelet discrimination algorithm in implantable cardioverter-defibrillator
by: Kazuya Mizukami, MD, PhD, et al.
Published: (2017-06-01)

Identification and management of right ventricular perforation using pacemaker and cardioverter-defibrillator leads: A case series and mini review
by: Mohammad Ali Akbarzadeh, MD, et al.
Published: (2017-02-01)

Potential clinical impact of cardiovascular magnetic resonance assessment of ejection fraction on eligibility for cardioverter defibrillator implantation
by: Joshi Subodh B, et al.
Published: (2012-10-01)

Lead Extractions are not Necessarily Required in the Treatment of Cases with Local Complications Unproven Resional/systemic Infection at the Pacemaker/ implantable Cardioverter Defibrillator (ICD) Site
by: Ryoji Kishi, MD, et al.
Published: (2005-01-01)

Successful intermuscular implantation of subcutaneous implantable cardioverter defibrillator in a Japanese patient with pectus excavatum
by: Yusuke Kondo, M.D., Ph.D., et al.
Published: (2017-02-01)

Cannot write session to /tmp/vufind_sessions/sess_npm8ujrcukvpa5mobsi6p5rhqa